Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase
暂无分享,去创建一个
Yasuhisa Fujii | A. Hata | T. Ariga | T. Uchiyama | G. Izumi | A. Takeda | Takatoshi Sato | S. Kurotobi | H. Ono | A. Ishiguro | H. Hanaoka | K. Hirono | F. Ichida | S. Takatsuki | Masataka Kato | S. Ozawa | H. Masuda | Y. Onouchi | M. Terai | K. Ouchi | T. Saji | Y. Nomura | T. Higaki | Nobuyuki Kakimoto | M. Ayusawa | M. Nakayashiro | M. Kamada | T. Fujiwara | Hiroyuki Suzuki | Y. Hashimura | Masaaki Yanai | A. Komori | S. Fuse | T. Takeuchi | T. Suenaga | Y. Ishiguchi | H. Minami | T. Soga | N. Takada | H. Hamada | T. Honda | K. Yasukawa | Y. Okajima | K. Masuda | Eiichi Yamamoto | Takeshi Nakano | J. Sato | Reiko Aoyagi | R. Ebata | Moe Terauchi | Aki Otsuki | S. Ogita | Kentaro Okunushi | Y. Okuma | M. Hanawa | Hironobu Kobayashi | Taisuke Nabeshima | Kiyotaka Takefuta | Naoki Ohno | Takahiro Nakamura | N. Nishi | K. Hirai | Nishihara Takahiro | Hideoki Yajima | Hideyasu Ooto | Y. Umeda | S. Suwabe | Yasushi Ueno | Yu Saito | Yutaka Kitani | N. Saito | You Okizuka | Keiichi Hirono | Sayaka Ozawa | Takamichi Uchiyama | Ryota Ebata